Skip to main content
Livermore
Livermore
ZHEN

High Net Worth Advisory Group LLC

SEC CIK
0001919142
Latest filing
Jul 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by High Net Worth Advisory Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
13
Since Q4 2021
Holdings of REGN by High Net Worth Advisory Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−302−100.0%Sold outHolders
Q4 2024302$215.1K0.1%00.0%UnchangedHolders
Q3 2024302$317.5K0.1%00.0%UnchangedHolders
Q2 2024302$317.4K0.1%00.0%UnchangedHolders
Q1 2024302$290.7K0.1%00.0%UnchangedHolders
Q4 2023302$265.2K0.1%00.0%UnchangedHolders
Q3 2023302$248.5K0.1%00.0%UnchangedHolders
Q2 2023302$217.0K0.1%+26+9.4%AddedHolders
Q1 2023276$226.8K0.1%+26+10.4%AddedHolders
Q4 2022250$180.4K0.1%00.0%UnchangedHolders
Q3 2022250$172.0K0.1%00.0%UnchangedHolders
Q2 2022250$148.0K0.1%00.0%UnchangedHolders
Q1 2022250$175.0K0.1%00.0%UnchangedHolders
Q4 2021250$158.0K0.1%–No prior filingHolders